New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 13, 2014
07:53 EDTCRMECardiome's Brinavess shows positive results in cardiological study
Cardiome announced that an independent, investigator-led investigation demonstrated real-world cardioversion experience with Brinavess RINAVESS (vernakalant IV) in patients who developed post-cardiac surgery atrial fibrillation. This was a prospective, non-randomised, single-arm study in 50 patients. The primary outcome was the conversion of atrial fibrillation to sinus rhythm 90 minutes post-Brinavess RINAVESS infusion. Brinavess was successful in cardioverting 74% of the patients.
News For CRME From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 14, 2015
08:56 EDTCRMECardiome Aggrastat sales likely to bounce back, says Canaccord
Subscribe for More Information
May 13, 2015
07:06 EDTCRMECardiome still sees FY15 Aggrastat sales $24M-$25M
Subscribe for More Information
07:05 EDTCRMECardiome reports Q1 EPS 823c), consensus (30c)
Subscribe for More Information
May 12, 2015
08:40 EDTCRMECardiome enters into commercialization agreement with AOP Orphan Pharma
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use